FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
Back to search
Official data from USPTO
MEDELPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
05/30/2023
Classification
Registered
Trademark type
Word
Nice classes
9
Filing date
08/02/2021
Registration date
01/31/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2023
Last transaction
01/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
SCHLEGELMILCH, JONATHON A
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MEDELPHARM
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Machines for testing and evaluating the compressibility of pharmaceutical ingredients for the production of pharmaceutical products in the form of tablets; Scientific equipment, namely, machines for the compressing of small amounts of tablets with pharmaceutically active and inactive ingredients pre-dosed in the form of tablets; Scientific equipment, namely, machines for compressing small amounts of tablets with pharmaceutically active and inactive ingredients pre-dosed in the form of tablets for facilitating pharmaceutical research and development; computer controls for the operation of machines for the production of pharmaceutical products in the form of tablets; Downloadable computer software for the production of pharmaceutical tablets; Downloadable computer software for analyzing pharmaceutical products; Downloadable computer software for manufacturing machines for pharmaceutical products, in the nature of pharmaceutical tablets; Downloadable computer software for automation of machines, and for manufacturing pharmaceutical products; Downloadable computer software for analysis, testing, and control of machines used for manufacturing pharmaceutical products, and for manufacturing tablets for the pharmaceutical industry
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2023
FIMP
FINAL DISPOSITION PROCESSED
05/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2022
PUBO
PUBLISHED FOR OPPOSITION
11/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2022
RFNT
REFUSAL PROCESSED BY IB
06/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/13/2022
RFRR
REFUSAL PROCESSED BY MPU
05/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/12/2022
CNRT
NON-FINAL ACTION WRITTEN
05/11/2022
DOCK
ASSIGNED TO EXAMINER
04/29/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens MEDELPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.